Publicaciones en colaboración con investigadoras/es de Complejo Asistencial Universitario de Burgos (13)

2020

  1. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

2019

  1. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

2018

  1. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

2015

  1. Pharmacogenomic biomarkers for colorectal cancer treatment

    Cancer Treatment Communications

2013

  1. Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations

    PLoS ONE, Vol. 8, Núm. 2

2012

  1. Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy

    Biochemistry and Cell Biology, Vol. 90, Núm. 2, pp. 173-178

  2. KRAS assay selection: Sensitivity and accuracy in clinical application

    Molecular Biology Reports, Vol. 39, Núm. 3, pp. 2467-2470

  3. No evidence for PML-RARa bcr1 fusion gene in colorectal cancer

    Molecular Biology Reports, Vol. 39, Núm. 5, pp. 5387-5391

2011

  1. KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer

    Molecular Biology Reports, Vol. 38, Núm. 2, pp. 1315-1320

  2. PIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population

    Molecular Biology Reports, Vol. 38, Núm. 2, pp. 1347-1351

2010

  1. Estrés oxidativo en el infarto cerebral

    Revista Electrónica de Biomedicina, Núm. 3, pp. 21-26

  2. No evidence for JAK2 V617F mutation in colorectal cancer

    British Journal of Biomedical Science, Vol. 67, Núm. 4, pp. 220-222

  3. TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status

    Journal of Translational Medicine, Vol. 8